Chr. Hansen is a global, differentiated bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. Chr. Hansen produces HMO (Human Milk Oligosaccharides) used in infant formula at their production facilities in Kalundborg.
Chr. Hansen took over the factory in 2020, which among other factors, were driven by Kalundborg’s dense underwood of skilled subcontractors, the city’s biotech and educational environment as well as the famous industrial symbiosis.